QANDLI DIABET (II TUR): SABABLARI, OLDINI OLISH VA DAVOLASH.

Authors

  • Shodmonova Mohlaroy Zafarbek qizi Quqon universiteti Andijon filiali PhD

Keywords:

II tur qandli diabet, insulin rezistentligi, giperglikemiya, metabolik sindrom, profilaktika, metformin, HbA1c, epidemiologiya.

Abstract

Mazkur tezisda II tur qandli diabetning (T2DM) etiologiyasi, patogenezi, xavf omillari, profilaktikasi va davolash tamoyillari ilmiy manbalar asosida tahlil qilinadi. Jahon sog‘liqni saqlash tashkiloti (WHO) ma’lumotlariga ko‘ra, diabet global sog‘liqni saqlash muammosi bo‘lib, 2021 yilda dunyo bo‘yicha 537 million kattalarda diabet aniqlangan, ularning aksariyati II turga to‘g‘ri keladi [1]. Kasallikning asosiy mexanizmi insulin rezistentligi va beta-hujayralar disfunksiyasi bilan bog‘liq [2]. Profilaktik choralar, jumladan, vaznni nazorat qilish va jismoniy faollik, kasallik rivojlanish xavfini sezilarli kamaytirishi ilmiy tadqiqotlarda isbotlangan [3]. Davolashda hayot tarzini o‘zgartirish, metformin birinchi qator preparati sifatida qo‘llanilishi va zarur hollarda kombinatsiyalangan terapiya tavsiya etiladi [4].

References

[1] World Health Organization. Global report on diabetes. Geneva: WHO; 2016. p. 6–12.

[2] American Diabetes Association. Standards of Medical Care in Diabetes—2023. Diabetes Care. 2023;46(Suppl.1):S19–S40.

[3] Knowler WC et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403 (p. 393–398).

[4] American Diabetes Association. Pharmacologic Approaches to Glycemic Treatment. Diabetes Care. 2023;46(Suppl.1):S140–S157.

[5] International Diabetes Federation. IDF Diabetes Atlas, 10th ed. Brussels; 2021. p. 34–45.

[6] UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin. Lancet. 1998;352:837–853 (p. 837–845).

[7] Zinman B et al. Empagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;373:2117–2128 (p. 2119–2125).

[8] DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;88(4):787–835 (p. 790–802).

[9] Nathan DM et al. Medical management of hyperglycemia in type 2 diabetes. Diabetes Care. 2009;32:193–203 (p. 194–199).

[10] World Health Organization. Diagnosis and classification of diabetes mellitus. Geneva; 2019. p. 15–22.

[11] International Diabetes Federation. Clinical Practice Recommendations. 2017; p. 10–18.

[12] Grundy SM. Metabolic syndrome update. Circulation. 2004;109:433–438 (p. 435–437).

Downloads

Published

2026-02-14

Conference Proceedings Volume

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.